225 related articles for article (PubMed ID: 20977743)
1. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.
White CD; Khurana H; Gnatenko DV; Li Z; Odze RD; Sacks DB; Schmidt VA
BMC Gastroenterol; 2010 Oct; 10():125. PubMed ID: 20977743
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
3. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.
Zoheir KM; Abd-Rabou AA; Harisa GI; Kumar A; Ahmad SF; Ansari MA; Abd-Allah AR
Tumour Biol; 2016 Oct; 37(10):13927-13939. PubMed ID: 27488117
[TBL] [Abstract][Full Text] [Related]
4. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent.
Schmidt VA; Chiariello CS; Capilla E; Miller F; Bahou WF
Mol Cell Biol; 2008 Mar; 28(5):1489-502. PubMed ID: 18180285
[TBL] [Abstract][Full Text] [Related]
5. Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.
Gnatenko DV; Xu X; Zhu W; Schmidt VA
PLoS One; 2013; 8(8):e71826. PubMed ID: 23951254
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression.
Zoheir KM; Abd-Rabou AA; Harisa GI; Ashour AE; Ahmad SF; Attia SM; Bakheet SA; Abdel-Hamied HE; Abd-Allah AR; Kumar A
Int J Clin Exp Pathol; 2015; 8(8):8821-31. PubMed ID: 26464624
[TBL] [Abstract][Full Text] [Related]
7. The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo.
Jin X; Liu Y; Liu J; Lu W; Liang Z; Zhang D; Liu G; Zhu H; Xu N; Liang S
PLoS One; 2015; 10(8):e0133770. PubMed ID: 26252773
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma.
Dai Q; Song F; Li X; Huang F; Zhao H
BMC Cancer; 2022 Nov; 22(1):1121. PubMed ID: 36320006
[TBL] [Abstract][Full Text] [Related]
9. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
Jin SH; Akiyama Y; Fukamachi H; Yanagihara K; Akashi T; Yuasa Y
Int J Cancer; 2008 Mar; 122(5):1040-6. PubMed ID: 17957782
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.
Kumar D; Hassan MK; Pattnaik N; Mohapatra N; Dixit M
PLoS One; 2017; 12(10):e0186977. PubMed ID: 29073199
[TBL] [Abstract][Full Text] [Related]
11. New Approach about the Signaling Crosstalk between IQGAPs/ NF- κB/IL-8 and PDCD5/p53/TRAIL Pathways that Modulate Malignant Transformation in Hepatocellular Carcinoma.
Zoheir KMA; Abdelhafez MA; Darwish AM; Mahrous KF
Asian Pac J Cancer Prev; 2022 Jan; 23(1):271-279. PubMed ID: 35092397
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
13. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
14. Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling.
Delgado ER; Erickson HL; Tao J; Monga SP; Duncan AW; Anakk S
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526450
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
16. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y
Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
[TBL] [Abstract][Full Text] [Related]
19. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
